Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Stephen C. Rodriguez |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study / Larry Alphs en The Journal of Clinical Psychiatry, Año 2014 - Vol.75 - No.12 (Diciembre)
[artículo]
Título : Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study : a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia Tipo de documento: texto impreso Autores: Larry Alphs, Autor ; Lian Mao, Autor ; Stephen C. Rodriguez, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1388-1393 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hospitalización, Isoxazoles - inyección, Palmitato de paliperidona, Esquizofrenia. Resumen: Public health considerations require that clinical trials address the complex "real-world" needs of patients with chronic illnesses. This is particularly true for persons with schizophrenia, whose management is frequently complicated by factors such as comorbid substance abuse, homelessness, and contact with the criminal justice system. Link: ./index.php?lvl=notice_display&id=27852
in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.12 (Diciembre) . - pp. 1388-1393[artículo] Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study : a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia [texto impreso] / Larry Alphs, Autor ; Lian Mao, Autor ; Stephen C. Rodriguez, Autor . - 2022 . - pp. 1388-1393.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.12 (Diciembre) . - pp. 1388-1393
Palabras clave: Antipsicóticos, Hospitalización, Isoxazoles - inyección, Palmitato de paliperidona, Esquizofrenia. Resumen: Public health considerations require that clinical trials address the complex "real-world" needs of patients with chronic illnesses. This is particularly true for persons with schizophrenia, whose management is frequently complicated by factors such as comorbid substance abuse, homelessness, and contact with the criminal justice system. Link: ./index.php?lvl=notice_display&id=27852